Spots Global Cancer Trial Database for Efficacy and Safety Study of Endoscopic Submucosal Dissection for Early Gastric Cancer

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Efficacy and Safety Study of Endoscopic Submucosal Dissection for Early Gastric Cancer

Official Title: Long-term Follow-up After Endoscopic Submucosal Dissection for Early Gastric Cancer

Study ID: NCT01132469

Conditions

Endoscopic Submucosal Dissection

Early Gastric Cancer

Multi-center, Single-arm Clinical Trial

Historical Control Group

Quality of Life and Cost Analysis

Interventions

Endoscopic Submucosal Dissection

Study Description

Brief Summary: The purpose of this study is to evaluate the safety and clinical effectiveness of ESD(Endoscopic Submucosal Dissection) for early gastric cancer analyzing short-term and long-term results of endoscopic treatment.

Detailed Description: Traditionally open-gastrectomy is the standard treatment for gastric cancer without distant metastasis, but high mortality and morbidity, the intense weight loss, food intake difficulties after surgery are fraught, including problems with the drawback of significantly degrading the quality of life. Therefore, a lot of effort to seek the more simple treatment than open gastrectomy has been made, recently the endoscopic treatment for early gastric cancer is the most widely used treatment. This single-arm, multi-center study enroll early gastric cancer patients after ESD compared with the retrospective control(surgical treatment) group considering the unreality of the randomized clinical trials. In addition, the quality of life assessment by the EORTC C30/STO22 tools before and after ESD procedure in enrolled patients will be performed and the direct cost analysis also will be conducted.